MGC Pharmaceuticals Financials
MGCLFDelisted Stock | USD 0.21 0.00 0.00% |
With this module, you can analyze MGC financials for your investing period. You should be able to track the changes in MGC Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
MGC |
Understanding current and past MGC Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of MGC Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in MGC Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in MGC Pharmaceuticals' official financial statements typically reflect MGC Pharmaceuticals' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving MGC Pharmaceuticals' quantitative information. For example, before you start analyzing numbers published by MGC accountants, it's essential to understand MGC Pharmaceuticals' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
MGC Pharmaceuticals Stock Summary
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia. Mgc Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Instrument | USA OTC Stock View All |
Exchange | OTCQB Exchange |
ISIN | AU000000MXC6 |
Business Address | 1202 Hay Street, |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | mgcpharma.com.au |
Phone | 61 8 6382 3390 |
Currency | USD - US Dollar |
MGC Pharmaceuticals Key Financial Ratios
There are many critical financial ratios that MGC Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that MGC Pharmaceuticals reports annually and quarterly.MGC Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MGC Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare MGC Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MGC Pharmaceuticals competition to find correlations between indicators driving MGC Pharmaceuticals's intrinsic value. More Info.MGC Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MGC Pharmaceuticals' earnings, one of the primary drivers of an investment's value.MGC Pharmaceuticals Market Pulse
Quote | 0.21 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 0.21 |
Low | 0.21 |
High | 0.21 |
Volume | 0 |
Exchange | OTCQB |
MGC Pharmaceuticals November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MGC Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MGC Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of MGC Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing MGC OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MGC Pharmaceuticals's daily price indicators and compare them against related drivers.
Information Ratio | (0.16) | |||
Maximum Drawdown | 29.91 | |||
Value At Risk | (3.70) |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in MGC OTC Stock
If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |